JONATHAN A. MYERS, MD

Dr. Myers, DayOne Health’s medical director of the Chicago clinic, has received special training in LAP-BAND® surgery. He completed his fellowship training in Minimally Invasive Surgery at Loyola University Medical Center and performed his residency at Rush University Medical Center and Cook County Hospital. As a resident, Dr. Myers achieved many honors. He was Chief Administrative Resident, was awarded the Society of Laparoendoscopic Surgeons’ Outstanding Laparoendoscopic Surgeon Award, and was credited with developing the Minimally Invasive Training Center at Rush.

Dr. Myers is board certified in General Surgery and is currently an Assistant Professor of Surgery at Rush Medical College. His special interests include minimally invasive surgery, surgery of the gastrointestinal tract, and biliopancreatic surgery. In addition to laparoscopic adjustable gastric banding, he performs laparoscopic esophagectomy, gastrectomy, and pancreas resection, as well as other new and innovative minimally invasive procedures.

Dr. Myers has been certified by the American Society for Metabolic and Bariatric Surgery (ASMBS) as a Bariatric Surgery Center of Excellence® physician. He is also one of the few bariatric surgeons in the country skilled in single-incision laparoscopic adjustable gastric banding.

Dr. Myers has published numerous articles in peer reviewed journals, authored book chapters, and presented his research at national meetings, including the Society of American Gastrointestinal and Endoscopic Surgeons and the American Society for Bariatric Surgery.


Important LAP-BAND® System Safety Information

Indications: The LAP-BAND® System is indicated for weight reduction for patients with obesity, with a Body Mass Index (BMI) of at least 40 kg/m2 or a BMI of at least 30 kg/m2with one or more obesity-related co-morbid conditions. It is indicated for use only in adult patients who have failed more conservative weight reduction alternatives, such as supervised diet, exercise and behavior modification programs. Patients who elect to have this surgery must make the commitment to accept significant changes in their eating habits for the rest of their lives.

Contraindications: The LAP-BAND® System is not recommended for non-adult patients, patients with conditions that may make them poor surgical candidates or increase the risk of poor results (e.g., inflammatory or cardiopulmonary diseases, GI conditions, symptoms or family history of autoimmune disease, cirrhosis), who are unwilling or unable to comply with the required dietary restrictions, who have alcohol or drug addictions, or who currently are or may be pregnant.

Warnings: The LAP-BAND® System is a long-term implant. Explant and replacement surgery may be required. Patients who become pregnant or severely ill, or who require more extensive nutrition may require deflation of their bands. Anti-inflammatory agents, such as aspirin, should be used with caution and may contribute to an increased risk of band erosion.

Adverse Events: Placement of the LAP-BAND® System is major surgery and, as with any surgery, death can occur. Possible complications include the risks associated with the medications and methods used during surgery, the risks associated with any surgical procedure, and the patient’s ability to tolerate a foreign object implanted in the body. Band slippage, erosion and deflation, reflux, obstruction of the stomach, dilation of the esophagus, infection, or nausea and vomiting may occur. Reoperation may be required. Rapid weight loss may result in complications that may require additional surgery. Deflation of the band may alleviate excessively rapid weight loss or esophageal dilation.

Important: For full safety information please click here, talk with your doctor, or call Apollo Customer Support at 1-855-551-3123


CAUTION: Rx only.